Is BioNTech SE (BNTX) A Good Stock To Buy Now? [Yahoo! Finance]
Moderna, Inc. (MRNA)
Last moderna, inc. earnings: 2/26 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
marinabio.com/investor-relations
Company Research
Source: Yahoo! Finance
BioNTech SE's share was trading at $103.80 as of March 4th. BNTX's trailing and forward P/E were 166.87 and 7.04 respectively according to Yahoo Finance. Best Biotech ETFs To Buy Photo by National Cancer Institute on Unsplash BioNTech SE (BNTX) has transitioned from a COVID-19 vaccine pioneer to a diversified biotech company with a growing focus on oncology, positioning itself for potential upside despite near-term uncertainties. After its initial success with the mRNA COVID vaccine in partnership with Pfizer, BioNTech has expanded its technology platform through strategic acquisitions, including the purchase of Chinese startup Biotheseus. This acquisition quickly yielded a landmark deal with Bristol Myers for BNT327, generating $2 billion in upfront payments plus a 50% royalty share, highlighting BioNTech's ability to capitalize on high-value pipeline opportunities. Financially, the company enters 2026 with a robust €17.2 billion cash position against a market capitalization
Show less
Read more
Impact Snapshot
Event Time:
MRNA
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MRNA alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MRNA alerts
High impacting Moderna, Inc. news events
Weekly update
A roundup of the hottest topics
MRNA
News
- Moderna (MRNA) Climbs 16% as Arbutus-Genevant Legal Battle Clears [Yahoo! Finance]Yahoo! Finance
- The Sun Will Shine On Moderna Again - Initiating With A Buy [Seeking Alpha]Seeking Alpha
- Is Moderna Stock Outperforming the Dow? [Yahoo! Finance]Yahoo! Finance
- Why Moderna's $950M Patent Bill Is A Small Price For Pipeline Freedom [Seeking Alpha]Seeking Alpha
- Moderna to pay up to $2.25B to settle COVID vaccine patent matter [Yahoo! Finance]Yahoo! Finance
MRNA
Earnings
- 2/13/26 - Beat
MRNA
Sec Filings
- 3/5/26 - Form 8-K
- 3/3/26 - Form 4
- 3/3/26 - Form 4
- MRNA's page on the SEC website